Firefly Neuroscience (AIFF) Fundamental Analysis: Revenue, Earnings & Valuation

8.58 / 10

Outperform

Fundamental evaluation rates Outperform with an 8.6/10 score. Strengths include Profit‑MV, Operating cycle, Inventory turnover and Days sales outstanding, delivering solid returns. Weak points are Asset‑MV and a modest Equity multiplier, which slightly dampen the otherwise strong financial profile.

Analysis Checks(7/10)

Asset-liability ratio (%)

Value22.16

Score1/3

Weight-0.77%

1M Return-0.20%

Operating cycle

Value40.45

Score3/3

Weight28.97%

1M Return6.96%

Days sales outstanding

Value71.97

Score3/3

Weight23.00%

1M Return5.76%

Profit-MV

Value0.41

Score2/3

Weight-0.73%

1M Return-0.21%

Current assets turnover ratio

Value0.18

Score3/3

Weight19.14%

1M Return4.61%

Long-term debt to working capital ratio (%)

Value0.01

Score2/3

Weight5.72%

1M Return1.39%

Asset-MV

Value-0.48

Score0/3

Weight-16.96%

1M Return-6.04%

Equity multiplier (DuPont analysis %)

Value1.83

Score1/3

Weight0.93%

1M Return0.23%

Inventory turnover days

Value40.45

Score2/3

Weight15.04%

1M Return3.65%

Net profit / Total profit (%)

Value100.02

Score3/3

Weight25.65%

1M Return6.74%

Is AIFF undervalued or overvalued?

AIFF scores 8.58/10 on fundamentals and holds a Discounted valuation at present. Backed by its -469.98% ROE, -2705.87% net margin, -1.68 P/E ratio, 4.45 P/B ratio, and -53.74% earnings growth, these metrics solidify its Outperform investment rating.